跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BICALUTAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BICALUTAMIDE
Authorized
STANDARD
BICALUTAMIDE
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f9febb0d52da5402
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
f9febb0d52da5402
Drug Approval Canada Name
BICALUTAMIDE
Product Name
BICALUTAMIDE
Status
Marketed
Status Date
2022-04-28
Original Market Date
2022-04-28
Din
02519178
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L02BB03 BICALUTAMIDE
Atc Name
l 02 bb 03
Aig Number
0127996001
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
BICALUTAMIDE
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f9febb0d52da5402
Type
Standard
Back to Health Canada Approvals